2m 2m 2m 2m 2m 2m 2m
4Front Ventur-SV (FFNTF)
OTC
$0.000001$0.00 (0.00%)
Price as of May 28, 2026- $913.00Market Cap
- -99.75%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
4Front Ventur-SV (FFNTF)
$0.000001$0.00 (0.00%)
FFNTF | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | $0.00 (0.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 44,256 | ||
30-Day Average Volume | 15,993 | ||
1-Week Change | 0.00% | ||
1-Month Change | -90.00% | ||
1-Year Change | -99.75% | ||
3-Year Change | -100.00% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 913.9M | ||
Total Assets | $278.1M | ||
Market Cap | $913.00 | ||
Enterprise Value | $27.6M | ||
Period: QTR TTM FY | |||
Revenue | $17.1M | ||
Net Income | -$6.4M | ||
Free Cash Flow | -$562,000.00 | ||
EBIT | -$5.5M | ||
EBITDA | -$4.4M | ||
Net Working Capital | -$74.8M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | 2 | ||
P/B | -0 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -0 | ||
Price/Operating Cash Flow | -0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||